Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer.

Theranostics

Schwarzenböck S, Souvatzoglou M, Krause BJ.
PMID: 22448198
Theranostics. 2012;2(3):318-30. doi: 10.7150/thno.4008. Epub 2012 Mar 15.

PET and PET/CT using [(11)C]- and [(18)F]-labelled choline derivates is increasingly being used for imaging of primary and recurrent prostate cancer. While PET and PET/CT with [(11)C]- and [(18)F]-labelled choline derivates in patients suffering from biochemical recurrence of prostate...

Cite
Schwarzenböck S, Souvatzoglou M, Krause BJ. Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer. Theranostics. 2012;2(3):318-30doi: 10.7150/thno.4008.
Schwarzenböck, S., Souvatzoglou, M., & Krause, B. J. (2012). Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer. Theranostics, 2(3), 318-30. https://doi.org/10.7150/thno.4008
Schwarzenböck, S, et al. "Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer." Theranostics vol. 2,3 (2012): 318-30. doi: https://doi.org/10.7150/thno.4008
Schwarzenböck S, Souvatzoglou M, Krause BJ. Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer. Theranostics. 2012;2(3):318-30. doi: 10.7150/thno.4008. Epub 2012 Mar 15. PMID: 22448198; PMCID: PMC3311230.
Copy Download .nbib Format: NLM
Acute Acalculous Cholecystitis with Empyema due to Salmonellosis.

Case reports in gastrointestinal medicine

Lianos GD, Drosou P, Souvatzoglou R, Karampa A, Vangelis G, Angelakis E, Pappas V, Lekkas E.
PMID: 31183222
Case Rep Gastrointest Med. 2019 Apr 30;2019:5185314. doi: 10.1155/2019/5185314. eCollection 2019.

Empyema of acalculous gallbladder in the setting of salmonellosis represents an extremely rare and life-threatening clinical condition in adults. In this unique case report, we deal with a previously healthy patient who developed acalculous cholecystitis and empyema due to...

Cite
Lianos GD, Drosou P, Souvatzoglou R, et al. Acute Acalculous Cholecystitis with Empyema due to Salmonellosis. Case Rep Gastrointest Med. 2019;2019:5185314doi: 10.1155/2019/5185314.
Lianos, G. D., Drosou, P., Souvatzoglou, R., Karampa, A., Vangelis, G., Angelakis, E., Pappas, V., & Lekkas, E. (2019). Acute Acalculous Cholecystitis with Empyema due to Salmonellosis. Case reports in gastrointestinal medicine, 20195185314. https://doi.org/10.1155/2019/5185314
Lianos, Georgios D, et al. "Acute Acalculous Cholecystitis with Empyema due to Salmonellosis." Case reports in gastrointestinal medicine vol. 2019 (2019): 5185314. doi: https://doi.org/10.1155/2019/5185314
Lianos GD, Drosou P, Souvatzoglou R, Karampa A, Vangelis G, Angelakis E, Pappas V, Lekkas E. Acute Acalculous Cholecystitis with Empyema due to Salmonellosis. Case Rep Gastrointest Med. 2019 Apr 30;2019:5185314. doi: 10.1155/2019/5185314. eCollection 2019. PMID: 31183222; PMCID: PMC6515067.
Copy Download .nbib Format: NLM
Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature.

Experimental hematology & oncology

Schweneker K, Clemm C, Brügel M, Souvatzoglou M, Hermisson M, Schmidt-Graf F, Zimmer C, Peschel C, Jost PJ.
PMID: 25954595
Exp Hematol Oncol. 2014 Dec 17;3:29. doi: 10.1186/2162-3619-3-29. eCollection 2014.

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults. Despite the use of optimized first-line therapy, GBM is still associated with a poor prognosis and an effective second-line therapy remains an important challenge in this...

Cite
Schweneker K, Clemm C, Brügel M, et al. Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature. Exp Hematol Oncol. 2014;3:29doi: 10.1186/2162-3619-3-29.
Schweneker, K., Clemm, C., Brügel, M., Souvatzoglou, M., Hermisson, M., Schmidt-Graf, F., Zimmer, C., Peschel, C., & Jost, P. J. (2014). Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature. Experimental hematology & oncology, 329. https://doi.org/10.1186/2162-3619-3-29
Schweneker, Katrin, et al. "Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature." Experimental hematology & oncology vol. 3 (2014): 29. doi: https://doi.org/10.1186/2162-3619-3-29
Schweneker K, Clemm C, Brügel M, Souvatzoglou M, Hermisson M, Schmidt-Graf F, Zimmer C, Peschel C, Jost PJ. Effective long-term treatment with bevacizumab for relapsed glioblastoma: case report and review of the literature. Exp Hematol Oncol. 2014 Dec 17;3:29. doi: 10.1186/2162-3619-3-29. eCollection 2014. PMID: 25954595; PMCID: PMC4423626.
Copy Download .nbib Format: NLM
PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Rauscher I, Eiber M, Souvatzoglou M, Schwaiger M, Beer AJ.
PMID: 24819421
J Nucl Med. 2014 Jun 01;55:25S-31S. doi: 10.2967/jnumed.113.129536. Epub 2014 May 12.

PET/MR is a new multimodal imaging technique that is expected to improve diagnostic performance, especially in oncologic patients in certain indications. Apart from the clinical relevance of PET with

Cite
Rauscher I, Eiber M, Souvatzoglou M, et al. PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications. J Nucl Med. 2014;55:25S-31Sdoi: 10.2967/jnumed.113.129536.
Rauscher, I., Eiber, M., Souvatzoglou, M., Schwaiger, M., & Beer, A. J. (2014). PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 5525S-31S. https://doi.org/10.2967/jnumed.113.129536
Rauscher, Isabel, et al. "PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 55 (2014): 25S-31S. doi: https://doi.org/10.2967/jnumed.113.129536
Rauscher I, Eiber M, Souvatzoglou M, Schwaiger M, Beer AJ. PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications. J Nucl Med. 2014 Jun 01;55:25S-31S. doi: 10.2967/jnumed.113.129536. Epub 2014 May 12. PMID: 24819421.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries